Celgene Corp (NASDAQ:CELG)

95.24
Delayed Data
As of 4:00pm ET
 -0.39 / -0.41%
Today’s Change
58.59
Today|||52-Week Range
97.07
+48.60%
Year-to-Date
5 ROE Stocks to Buy as Trade Concerns Spur Market Volatility
9:31am / Zacks.comZAK - Paid Partner Content
Dr. Michael Burry Buys 3 Stocks, Makes JD.com Largest Position in 1st Quarter
May 22 / GuruFocus NewsGURU - Paid Partner Content
Ocean Capital Management, LLC Buys Lululemon Athletica Inc, Deckers Outdoor Corp, YET...
May 23 / GuruFocus NewsGURU - Paid Partner Content
Mallinckrodt (MNK) Down After Filing Suit Against HHS and CMS
May 22 / Zacks.comZAK - Paid Partner Content
Novartis Reports Data on Asthma Drug, Update from Annual Meet
May 23 / Zacks.comZAK - Paid Partner Content
Biotech Stock Roundup: Label Expansion for CELG's Drugs, Setback for IMGN
May 22 / Zacks.comZAK - Paid Partner Content
Hedge Funds' Favorite Bets in 1st-Quarter 2019
May 23 / GuruFocus NewsGURU - Paid Partner Content
3 Years In, Is the "Winners for a Thinking World" Stock Sampler Winning?
May 22 / MotleyFool.comFOO - Paid Partner Content
The Zacks Analyst Blog Highlights: Cambrex, Innoviva, Celgene, BioDelivery Sciences I...
May 23 / Zacks.comZAK - Paid Partner Content
John Paulson's Top 5 Buys in the 1st Quarter
May 21 / GuruFocus NewsGURU - Paid Partner Content

Today’s Trading

Previous close95.63
Today’s open95.79
Day’s range95.19 - 96.02
Volume3,464,848
Average volume (3 months)8,772,613
Market cap--
Data as of 4:00pm ET, 05/24/2019

Growth & Valuation

Earnings growth (last year)+49.83%
Earnings growth (this year)+21.17%
Earnings growth (next 5 years)+18.40%
Revenue growth (last year)+19.26%
P/E ratio14.5
Price/Sales3.08
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-0.49-1.04%
TAKTakeda Pharmaceutica...+0.28+1.61%
ZTSZoetis Inc-0.49-0.48%
NVONovo Nordisk+0.21+0.43%
Data as of 4:04pm ET, 05/24/2019

Financials

Next reporting dateJuly 29, 2019
EPS forecast (this quarter)$2.62
Annual revenue (last year)$15.3B
Annual profit (last year)$4.0B
Net profit margin26.46%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
COO
Mark J. Alles
CFO, Principal Accounting Officer &
Executive VP
David V. Elkins
Corporate headquarters
Summit, New Jersey

Forecasts